نتایج جستجو برای: starting treatment dose

تعداد نتایج: 1692094  

Journal: :middle east journal of cancer 0
kholoud abu obead faculty of nursing , jordan university of science and technology, irbid, jordan sameer yaser king hussein cancer center, out patient clinic, amman, jordan maysaa khattab faculty of nursing , al-albayt university, al-mafraq, jordan faisal al-badainah king hussein cancer center, out patient clinic, amman, jordan laila saqer faculty of nursing , jordan university of science and technology, irbid, jordan nehaya al-dosouqi king hussein cancer center, out patient clinic, amman, jordan

background : the purposes of this study were to examine the impact of chemotherapy treatment on jordanian cancer patients’ fatigue and to correlate their fatigue with selected sociodemographic variables at the beginning of treatment and after four weeks of treatment. methods : this was a single group quasi-experimental correlational design study that enrolled 43 patients diagnosed with cancer w...

2015
Olaf GJ Naether Andreas Tandler-Schneider Wilma Bilger

PURPOSE This postmarketing surveillance survey was conducted to investigate the utility of the CONsistency in r-FSH Starting dOses for individualized tReatmenT (CONSORT) calculator for individualizing recombinant human follicle-stimulating hormone (r-hFSH) starting doses for controlled ovarian stimulation (COS) in routine clinical practice. METHODS This was a 3-year, open-label, observational...

2017
Sebastiaan D.T. Sassen Ron A.A. Mathôt Rob Pieters Robin Q.H. Kloos Valérie de Haas Gertjan J.L. Kaspers Cor van den Bos Wim J.E. Tissing Maroeska te Loo Marc B. Bierings Wouter J.W. Kollen Christian M. Zwaan Inge M. van der Sluis

Erwinia asparaginase is an important component in the treatment of pediatric acute lymphoblastic leukemia. A large variability in serum concentrations has been observed after intravenous Erwinia asparaginase. Currently, Dutch Childhood Oncology Group protocols dose alterations are based on trough concentrations to ensure adequate asparaginase activity (≥100 IU/L). The aim of this study was to d...

Journal: :Anticancer research 2005
Béla Szende Sándor Paku Gergely Rácz László Kopper

BACKGROUND Low molecular weight heparins (LMWH) have become increasingly important in anticoagulant therapy. Antitumor and antimetastatic activity of heparin and LMWH-s have also been reported. MATERIALS AND METHODS Fraxiparine, a new modified LMW-H, was tested for antimetastatic effect using 3LL-HH intravenous, B16 intra-foot pad and 3LL-HH intrasplenic models in C57 Bl/6 mice. The dose of F...

2010
Francesca Mori Neri Pucci Maria Elisabetta Rossi Maurizio de Martino Chiara Azzari Elio Novembre

A renewed interest in oral desensitization as treatment for food allergy has been observed in the last few years. We studied a novel method based on the end point skin prick test procedure to establish the starting dose for oral desensitization in a group of 30 children highly allergic to milk. The results (in terms of reactions to the first dose administered) were compared with a group of 20 c...

Journal: :BMC Cancer 2021

Abstract Background Afatinib has shown favorable response rates (RRs) and longer progression free survival (PFS) in lung cancer patients harboring EGFR mutations compared with standard platinum-based chemotherapy. However, serious adverse drug reactions (ADRs) limit the clinical application of afatinib. Methods We designed a retrospective study, enrolling all metastatic adenocarcinoma who were ...

Journal: :International journal of radiation oncology, biology, physics 2012
John M Robertson Jeffrey Margolis Robert P Jury Savitha Balaraman Matthew B Cotant Samer Ballouz Iqbal G Boxwala Ishmael A Jaiyesimi Laura Nadeau Maria Hardy-Carlson Kimberly S Marvin Michelle Wallace Hong Ye

PURPOSE To determine the recommended dose of radiotherapy when combined with full-dose gemcitabine and erlotinib for unresected pancreas cancer. METHODS AND MATERIALS Patients with unresected pancreatic cancer (Zubrod performance status 0-2) were eligible for the present study. Gemcitabine was given weekly for 7 weeks (1,000 mg/m(2)) with erlotinib daily for 8 weeks (100 mg). A final toxicity...

Journal: :British Journal of Psychiatry 2013

2014
Andrew S Tsiattalos Anita Patel

INTRODUCTION Chronic hepatitis C is a leading cause of severe liver disease. Protease inhibitors used to treat these patients are known to have many drug interactions, although there is limited data available between boceprevir and warfarin. This case report is the first in vivo drug interaction reported in the literature. CASE PRESENTATION A 73-year-old African American man was diagnosed wit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید